EUVIMEDAtrasti EUVIMED
Crossref

PLOD2 Promotes Cutaneous Squamous Cell Carcinoma Progression in Association With STAT3‐Related ERK and AKT Pathways

Ningyi Xian iD, Ziwei Wang, Bingqing Wang iD, Xiaofei Wang, Yan Zheng

Molecular Carcinogenesis · 2026-05 · 65 (5) · 615-629

DOI: 10.1002/mc.70102 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-03-01. Written by Ningyi Xian and 4 co-authors. Institution: Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Major MEDLINE topics: STAT3 Transcription Factor, Cutaneous Squamous Cell Carcinoma, Proto-Oncogene Proteins c-akt, Skin Neoplasms. 62 references. Funded by: the National Natural Science Foundation of China, Institutional Foundation of the 503 First Affiliated Hospital of Xi'an Jiaotong University.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Cutaneous squamous cell carcinoma (cSCC) is a malignant skin cancer which is derived from epidermal keratinocytes, and long‐term exposure to ultraviolet rays is its main risk factor. Procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 2 (PLOD2) is a crucial gene for the formation and stability of collagen intermolecular cross‐links, being vital in the development of cancer. Nevertheless, the interaction between cSCC and PLOD2 has not been elucidated. Here, we found PLOD2 upregulated in human cSCC. Its knockdown in cSCC cells suppressed proliferation, migration, invasion, and angiogenesis while inducing apoptosis and cell cycle arrest; overexpression promoted these malignant phenotypes. In mouse xenografts, PLOD2 knockdown inhibited tumor growth and collagen deposition. Furthermore, in a DMBA/TPA‐induced carcinogenesis model, topical PLOD2 inhibition by minoxidil suppressed tumor development as well. Mechanistically, our studies revealed that PLOD2 acts as a key downstream effector of STAT3 to activate ERK and AKT signaling evidenced by rescue experiments. As a result, our study not only establishes the STAT3/PLOD2/ERK‐AKT axis as a key driver of cSCC but also identifies the clinically approved drug minoxidil as a potent PLOD2 inhibitor, demonstrating immediate promise as a repurposed therapeutic agent.

Subjects

MeSH terms (MEDLINE)

STAT3 Transcription FactorCutaneous Squamous Cell CarcinomaProto-Oncogene Proteins c-aktSkin NeoplasmsProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseCarcinoma, Squamous CellHumansAnimalsMiceCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticApoptosisDisease ProgressionSignal TransductionCell MovementMAP Kinase Signaling SystemMinoxidilFemaleMice, Nude

Author keywords

PLOD2STAT3biomarkercutaneous squamous cell carcinomaminoxidil

Substances

STAT3 Transcription FactorProto-Oncogene Proteins c-aktSTAT3 protein, humanProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenasePLOD2 protein, humanMinoxidil

Authors and institutions

  • Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Gastroenterology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Dermatology and Aesthetic Medicine, Xi'an, Shaanxi, China.
  • Biomedical Experimental Center, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

ORCID profiles: Ningyi Xian, Bingqing Wang

Funding

  • the National Natural Science Foundation of China
  • Institutional Foundation of the 503 First Affiliated Hospital of Xi'an Jiaotong University

Cite

APA

Xian, N., Wang, Z., Wang, B., Wang, X., & Zheng, Y. (2026). PLOD2 Promotes Cutaneous Squamous Cell Carcinoma Progression in Association With STAT3‐Related ERK and AKT Pathways. Molecular Carcinogenesis, 65(5), 615-629. https://doi.org/10.1002/mc.70102

Vancouver

Xian N, Wang Z, Wang B, Wang X, Zheng Y. PLOD2 Promotes Cutaneous Squamous Cell Carcinoma Progression in Association With STAT3‐Related ERK and AKT Pathways. Molecular Carcinogenesis. 2026;65(5):615-629. doi:10.1002/mc.70102

BibTeX
@article{Xian2026,
  author = {Xian, Ningyi and Wang, Ziwei and Wang, Bingqing and Wang, Xiaofei and Zheng, Yan},
  title = {PLOD2 Promotes Cutaneous Squamous Cell Carcinoma Progression in Association With STAT3‐Related ERK and AKT Pathways},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {5},
  pages = {615--629},
  doi = {10.1002/mc.70102}
}
Start for free →